HARBIN, China, March 5 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), announced today that Mr. Shaoming Li, the Company's Chairman and CEO, and Ms. Yan Yi Chen, CFO, will present at the upcoming Rodman & Renshaw Annual China Investment Conference to be held on March 7-9, 2010.
During the conference, Company management will be available for one-on-one meetings with institutional investors. The Rodman & Renshaw Annual China Investment Conference is a three-day event which features tracks devoted to Agriculture, Auto, Cleantech & Energy, Consumer/Retail, Education, Healthcare, Industrial and Technology industries. For more information about the conference, please visit http://www.rodm.com/conferences .
About Renhuang Pharmaceuticals, Inc.
Renhuang Pharmaceuticals, Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its extensive distribution network of over 3,000 distributors and more than 70 sales centers across 24 provinces in China.
CONTACT: Company Contact: Renhuang Pharmaceuticals, Inc., Ms. Portia Tan,
IR Contact, +86-451-5392-5461, or ir@renhuang.com; Or CCG Investor
Relations: Ms. Lei Huang, Account Manager, +1-646-833-3417 (New York),
lei.huang@ccgir.com; Or Mr. Crocker Coulson, President, +1-646-213-1915
(New York), or crocker.coulson@ccgir.com
Web site: http://www.ccgirasia.com/
